Drug Trial Radar · NCT06046729
A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
352
Actual
Start
Oct 23, 2023
Primary completion
Sep 30, 2025
Study completion Aug 17, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Sep 21, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to find the appropriately safe and effective dose and dosing frequency for eltrekibart in adults with moderate-to-severe hidradenitis suppurativa (HS) for further clinical development. The study will last approximately 62 weeks and may include up to 31 visits.
Conditions
- Hidradenitis Suppurativa
Interventions
EltrekibartDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participant Achieving Hidradenitis Suppurativa Clinical Response 50 (HiSCR50)Time frame: Week 16
Locations
74 sites in 6 countries. Site status is shown where the registry gives one.
Medical Dermatology Specialists
Phoenix, Arizona
Saguaro Dermatology Associates, LLC - Probity - PPDS
Phoenix, Arizona
Arkansas Research Trials, LLC
North Little Rock, Arkansas
Northwest Arkansas Clinical Trials Center
Rogers, Arkansas
First OC Dermatology Research Inc
Fountain Valley, California
Center For Dermatology Clinical Research, Inc.
Fremont, California
Dermatology Research Associates
Los Angeles, California
Dermatology Institute and Skin Care Center
Santa Monica, California
University of Connecticut
Farmington, Connecticut
Direct Helpers Research Center
Hialeah, Florida
University of Miami
Miami, Florida
Skin Research of South Florida
Miami, Florida
ForCare Clinical Research
Tampa, Florida
Alliance Clinical Research of Tampa
Tampa, Florida
Olympian Clinical Research
Tampa, Florida
Advanced Medical Research, PC
Sandy Springs, Georgia
NorthShore Medical Group Dermatology - Skokie
Skokie, Illinois
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana
Equity Medical - Bowling Green
Bowling Green, Kentucky
Derm Research LLC
Louisville, Kentucky
Care Access-Marriottsville
Marriottsville, Maryland
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Revival Research Institute - Troy
Troy, Michigan
Washington University School of Medicine
St Louis, Missouri
Skin Specialists, P.C
Omaha, Nebraska
ActivMed Practices & Research, Inc.
Portsmouth, New Hampshire
Darst Dermatology
Charlotte, North Carolina
Dermatology Specialists of Charlotte
Charlotte, North Carolina
Duke University Medical Center
Durham, North Carolina
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Apex Clinical Research Center
Mayfield Heights, Ohio
DermDox Centers for Dermatology
Camp Hill, Pennsylvania
DermDox Dermatology Centers
Sugarloaf, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
Columbia Dermatology & Aesthetics
Columbia, South Carolina
International Clinical Research - Tennessee (IC Research)
Murfreesboro, Tennessee
Advanced Research Experts
Nashville, Tennessee
Modern Research Associates
Dallas, Texas
North Texas Clinical Research
Frisco, Texas
Jordan Valley Dermatology Center
South Jordan, Utah
Showing 40 of 74 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.